Published in Pharma Investments, Ventures and Law Weekly, September 19th, 2004
Globe, after evaluating its CAD/CAM designed parts for the prototype syringe, and with a view towards efficient large-scale manufacturing, is making design changes.
The safety syringes produced from the limited production run are expected to be used for testing, for mold design verification, as product samples, and to collect data for regulatory approvals in the U.S. and in selected Latin American countries.
Maxxon is a development stage...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly